Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Case Study · March 19, 2024

Treatment of VHL Disease–Associated Retinal Capillary Hemangioblastoma With Belzutifan in a Pediatric Patient

Retinal Cases & Brief Reports


Additional Info

Retinal Cases & Brief Reports
Successful Treatment of Von Hippel-Lindau (VHL) Disease-Associated Retinal Capillary Hemangioblastoma (RCH) with Belzutifan in a Pediatric Patient
Retin Cases Brief Rep 2023 Jul 13;[EPub Ahead of Print], AA Jones, NJ Schloemer, WJ Wirostko

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading